Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jonathan Moses

6PUBLICATIONS

27CO-AUTHORS

Immunogenetics (incl. genetic immunology)Child and adolescent developmentAdolescent healthRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Feb 06, 2026

Integrating intestinal ultrasound into routine clinical care improves prediction of biochemical disease activity in pediatric inflammatory bowel disease.

Perseus V Patel, Destiny J Zuniga, Alka Goyal

|May 02, 2025

HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

Jeremy Adler, Joseph A Galanko, Rana Ammoury

|May 01, 2025

Intensified Upadacitinib Dosing for Adolescent Patients with Acute Severe Ulcerative Colitis.

Perseus V Patel, Martina Rigmaiden, Alka Goyal

|Oct 18, 2024

HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.

Jeremy Adler, Joseph A Galanko, Rana Ammoury

|Oct 17, 2024

Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.

Jonathan Moses, Jeremy Adler, Shehzad A Saeed

|Mar 06, 2024

High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease.

Dawn R Ebach, Traci W Jester, Joseph A Galanko

Pageof 1

Frequent Collaborators

3 joint publications

Dawn R Ebach

3 joint publications

Joseph A Galanko

3 joint publications

Ann M Firestine

3 joint publications

Rana Ammoury

3 joint publications

Peter Margolis

3 joint publications

Kelly Sandberg

3 joint publications

Tiffany M Linville

3 joint publications

Jess L Kaplan

3 joint publications

Lisa Pitch

3 joint publications

Steven J Steiner

Frequent Collaborators

3 joint publications

Dawn R Ebach

3 joint publications

Joseph A Galanko

3 joint publications

Ann M Firestine

3 joint publications

Rana Ammoury

Top Related Videos

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on : Sep 01, 2017

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on : May 02, 2013

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos

Top Related Videos

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on : Sep 01, 2017

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on : May 02, 2013

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos